Anxiety

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) --

(MENAFN - PR Newswire) 81.8% of patients with bothersome tinnitus treated with Lenire at New York Hearing Doctors reported significant improvement in a real-world clinical setting.1,2 Patients ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Vistagen To Contact Him Directly To Discuss Their Options

SAN DIEGO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and...

Obsession with beating biological clock identified as damaging new addiction

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 12, 2026--

Vanda Pharmaceuticals (NASDAQ:VNDA) highlighted strong growth for its lead product Fanapt and detailed several late-stage regulatory and clinical milestones during its fourth-quarter and full-year 2025 earnings call, while also reporting a sharply wider net loss driven largely by a one-time, non-cash tax charge. Fanapt growth offset by Hetlioz pressure from generics Chief Executive Officer Dr. [...]

EMDR therapy is best known for helping people recover from trauma, but it may also benefit those with anxiety, depression, and other mental health conditions.

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) --

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vistagen (VTGN) To Contact Him Directly To Discuss Their Options

A new Yale study finds that adolescents with anxiety or depression fair better when doctors follow FDA approvals or professional treatment guidelines rather than freelancing off-label treatments.